(Q33813203)

29 July 2017

1 reference

title

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition (English)

1 reference

29 July 2017

0 references

D C Brater

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

American Journal of Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

107

1 reference

29 July 2017

issue

6A

1 reference

29 July 2017

page(s)

65S-70S; discussion 70S-71S

1 reference

Renal syndromes associated with nonsteroidal antiinflammatory drugs

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti-Inflammatory Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

The clinical significance of inhibition of renal prostaglandin synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Suppression of plasma renin activity by indomethacin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Increased renal secretion of norepinephrine and prostaglandin E2 during sodium depletion in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Acute interstitial nephritis with glomerulopathy due to nonsteroidal anti-inflammatory agents: a review of its clinical spectrum and effects of steroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

7 January 2021

Analgesic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Sulindac is not renal sparing in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Acute renal effects of sulindac and indomethacin in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Effects of nabumetone on prostanoid biosynthesis in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Nonsteroidal antiinflammatory drugs and their effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Cyclooxygenase-2 (COX-2) and the kidney: current status and potential perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

Incidence of hyperkalaemia induced by indomethacin in a hospital population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900369-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00369-1

1 reference

29 July 2017

1 reference